Abstract
Although various mycoplasma species have been found in man, only Mycoplasma pneumoniae is known to affect the human respiratory tract. Together with viral infections, Mycoplasma pneumoniae is among the most common causes of acute infections of the upper and lower respiratory tract in man [1]. Of a large series of patients with clinical symptoms of an acute respiratory infection seen over a 10-year period (1965–1975), 23% had antibody titers indicating the possibility of a recent infection with Mycoplasma pneumoniae.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Krech U, Price PC, Jung M: The laboratory diagnosis and epidemiology of mycoplasma pneumoniae in Switzerland. Infection 4: 33, 1976.
Fischman RA, Marschall KE, Kislak JW: Adult respiratory distress syndrome caused by mycoplasma pneumoniae. Chest 74: 471, 1978.
Reigner Ph, Domenighetti G, Feihl F, Bonjour JPh, Perret Cl: Syndrome de détresse respiratoire aigu sur infection à mycoplasme. Sch Med W 110: 220, 1980.
Kaufman JM, Cuvelier CA, Van der Straeten M: Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax 35: 140, 1980.
Murray HW, Masur H, Senterfit L, Roberts R: The protean manifestations of mycoplasma pneumoniae infection in adults. Am J Med 58: 229, 1975.
Levine DP, Lerner AM: The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin N Am 62: 961, 1978.
Twomey JA, Espir ML: Neurological manifestations and Mycoplasma pneumoniae infection. BMJ 2: 832, 1979.
Kingston JR, Chankock RM, Mufson MA, Hellman LP, James WD, Fox HH, Mankoma C, Boyers J: Eaton agent pneumonia. JAMA 176: 118, 1961.
Grayston JT, Alexander ER, Kenny GG, Clarke ER, Fremont JC, macColl Wa: Mycoplasma pneumoniae infections. J Am Med Assoc 191: 369, 1965.
Maisel JC, Babbitt LH, John TJ: Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung. JAMA 202: 287, 1967.
Jones MC: Mycoplasma pneumoniae. Practioner 203, 1969.
Jao RL, Finland M: Susceptibitity of Mycoplasma pneumoniae to 21 antibiotics in vitro. Am J med Sc 253: 639, 1967.
Foy HM, Ochs H, Davis SD, Kenny GE, Luce RR, Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis 127: 388, 1973.
Dc Vos M, Van der Straeten M, Druyts E: Myocarditis and severe bilateral bronchopneumoniae caused by Mycoplasma pneumoniae. Infection 1: 60, 1976.
Slotkin R, Clyde W, Denny FW: The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo. Am J Epid 86: 225, 1967.
Shames JM, George RB, Holliday WB, Rash JR, Mogabgab WJ: Comparison of antibiotics in the treatment of Mycoplasma pneumoniae. Arch Int Med 125: 680, 1970.
Ruhrmann G, Holthusen W, Noack B: Klinische und röntgenologische Beobachtungen zum Verlauf von Infektionen mit Mykoplasma pneumoniae im Kindesalter. Infection 5: 47, 1977.
Wenzel RP, Graven RB, Davies JA, Hendley JO, Hamory BH, Gwaltney JM, Jr: Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infec Dis 136: S204, 1977.
Smilack JD, Burgin WW, Moore WL, Sanford JP: Mycoplasma pneumoniae pneumonia and clindamycin therapy. JAMA 228: 729, 1974.
Hers JP: Clinical aspects of infection with Mycoplasma pneumoniae. Proc roy Soc Med 61: 1325, 1968.
Grady GF, Gilfillan RF: Relation of mycoplasma pneumoniae seroreactivity, Immunosuppression, and Chronic Disease to Legionnaires’ Disease. Annals Int Med 90: 607, 1979.
Davies BH, Edwards JH, Seaton A: Cross-reacting antibodies to micropolyspora faeni in mycoplasma pneumoniae infection. Clin Allergy 5: 217, 1975.
Fernald GW, Clyde WA, Denny FW: Nature of the immune response to mycoplasma pneumoniae. J Immunol 98: 1028, 1967.
Biberfeld P, Sterner G: Cell mediated immune response following mycoplasma pneumoniae infection in man. Clin exp imm 29: 17, 1974.
Fernald G: In vitro response of human lymphocytes to mycoplasma pneumoniae Inf Imun 5: 552, 1972.
Arai S, Hinuma Y, Matsomoto K, Nakamura T: Delayed hypersensitivity in hamsters infected with Mycoplasma pneumoniae as revealed by macrophage migration inhibition test. J Microbiol 15: 509, 1971.
Biberfeld G: Macrophage migration inhibition in response to experimental Mycoplasma pneumoniae infection in the hamster. J Immunol 110: 1146, 1973.
Brunner H, James WD, Horswood RL, Chanock RM: Experimental Mycoplasma pneumoniae infection of young guinea pigs. J Infect Dis 127: 315, 1973.
Taylor G: Immunity to mycoplasma infections of the respiratory tract: a review. Roy Soc Med 72: 520, 1979.
Noriega ED, Simberkoff MS, Gilroy FJ, Rahal JJ: Life-threatening Mycoplasma pneumoniae. JAMA 229: 1471, 1974.
Niitu Y, Hasegawa S, Suetake T, Kubota H, Komatsu S, Horikawa M: Resistance of mycoplasma pneumoniae to erythromycin and other antibiotics. J Pedr 76: 438, 1970.
Jones GR, Borthwick RC: Mycoplasma pneumoniae resistant to oxytetracycline: two case reports. Brit J Dis Chest 67: 119, 1973.
Stopler T, Gerichter CB, Branski D: Antibiotic-resistant mutants Of Mycoplasma pneumoniae. Isr J Med Sc 16: 169, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Van Der Straeten, M. (1981). Antibiotic Treatment of Mycoplasma Pneumoniae Infections. In: Van Furth, R. (eds) Developments in Antibiotic Treatment of Respiratory Infections. New Perspectives in Clinical Microbiology, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8305-2_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-8305-2_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8307-6
Online ISBN: 978-94-009-8305-2
eBook Packages: Springer Book Archive